Dual process theories postulate the existence of two levels of processing, Type 1, which uses belief-based cues to make very rapid inferences, and Type 2, which uses more conscious, working memory-based processes that are, in principle, capable of making rule-based judgments. There is a common assumption that Type 1 processes are more rapidly produced, while Type 2 processes take more time. Evidence for this assumption is mixed. Recently, Newman, Gibb, and Thompson (Journal of Experimental Psychology: Learning, Memory, and Cognition, 43(7): 1154, 2017) have provided clear evidence that very fast responses use a combination of both belief-based and rule-based cues. In these studies, we initially replicated this basic result with adults using a different methodology and extended them to examine in greater detail patterns of change with restricted time. The results also show the same combination of rule-based and belief-based cues in fast responses, and suggest that time constraints differentially affect each form of cue. We then examined the developmental pattern of both fast and slow responding. Children aged between 8 and 10 years of age were examined using the methodology of the initial study. Results show that both developmental patterns and the effect of reduced time on children produce parallel changes in both belief-based and rule-based responding. These results suggest the existence of two simultaneously developing processes, consistent with a dual-strategy model of reasoning.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3758/s13421-019-00927-3 | DOI Listing |
Sci Rep
January 2025
Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada.
People with amblyopia show deficits in global motion perception, especially at slow speeds. These observers are also known to have unstable fixation when viewing stationary fixation targets, relative to healthy controls. It is possible that poor fixation stability during motion viewing interferes with the fidelity of the input to motion-sensitive neurons in visual cortex.
View Article and Find Full Text PDFClin Lung Cancer
January 2025
Thoracic Surgery Unit, IRCCS National Cancer Institute Regina Elena, Rome, Italy.
Introduction: To analyze the impact of Kirsten-Rat-Sarcoma Virus (KRAS) mutations on tumor-growth as estimated by tumor-doubling-time (TDT) among solid-dominant clinical-stage I lung adenocarcinoma. Moreover, to evaluate the prognostic role of KRAS mutations, TDT and their combination in completely-resected pathologic-stage I adenocarcinomas.
Methods: In this single-center retrospective analysis, completely resected clinical-stage I adenocarcinomas presenting as solid-dominant nodules (consolidation-to-tumor ratio > 0.
Biomolecules
January 2025
Department of Physiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Rd., Wuhan 430030, China.
The sigma-1 receptor (Sig-1R) has emerged as a significant target in the realm of pain management and has been the subject of extensive research. Nonetheless, its specific function in inflammatory pain within dorsal root ganglion (DRG) neurons remains inadequately elucidated. This study utilized whole-cell patch clamp techniques, single-cell real-time PCR, and immunohistochemistry to examine the influence of Sig-1R on inflammatory pain induced by complete Freund's adjuvant (CFA) in a rat model.
View Article and Find Full Text PDFBiomolecules
December 2024
Department of Aerospace Medical Training, School of Aerospace Medicine, Fourth Military Medical University, Xi'an 710032, China.
Skeletal muscle atrophy, which is induced by factors such as disuse, spaceflight, certain medications, neurological disorders, and malnutrition, is a global health issue that lacks effective treatment. Hindlimb unloading is a commonly used model of muscle atrophy. However, the underlying mechanism of muscle atrophy induced by hindlimb unloading remains unclear, particularly from the perspective of the myocyte proteome and metabolism.
View Article and Find Full Text PDFAntibiotics (Basel)
January 2025
Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Servei d'Infectologia, Institut de Recerca Pediàtrica Sant Joan de Déu, 08950 Barcelona, Spain.
: Isoniazid (INH) remains a first-line drug for the treatment of tuberculosis (TB) in young children. In 2010, the WHO recommended an increase in the daily dose of INH up to 10 (7-15) mg/kg. Currently, there are no INH suspensions available in Europe.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!